Study ID: LN-LAQ-201 | 2010-018329-20
Study Title
- Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Teva Identifier
- LN-LAQ-201 | 2010-018329-20
ClinicalTrials.gov Identifier
- NCT01085097
Study Status
- Completed
Trial Condition(s)
- Lupus Nephritis
Interventions
- Drug: laquinimod | Drug: Mycophenolate Mofetil | Drug: prednisolone/prednisone | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 75 Years
Trial Duration
- 07/01/2010 - 12/01/2012
Phase
- Phase 2
Study Type
Interventional